What's in CAMC Health System's pipeline?

CAMC Health System has 5 drugs in our index: 5 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with CAMC Health System's portfolio?

Top competitors by shared drug class: Ajou University School of Medicine, GlaxoSmithKline, Hospital Universitari de Bellvitge, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Pfizer Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/camc-health-system.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

CAMC Health System — Portfolio Competitive Intelligence Brief

CAMC Health System pipeline: 5 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

5 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Neither Pregabalin nor Gabapentin	Neither Pregabalin nor Gabapentin	marketed	Anticonvulsant	Voltage-gated calcium channels	Pain
adjustment of the dosages of immunosuppressants	adjustment of the dosages of immunosuppressants	marketed
adjustment of immunosuppressant dosages	adjustment of immunosuppressant dosages	marketed
Naloxone and Docusate	Naloxone and Docusate	marketed	Opioid antagonist + stool softener combination	Opioid receptors (mu, delta, kappa) for naloxone; intestinal fluid secretion for docusate	Addiction Medicine / Pain Management
VersaPro Cream Base for Compounding	VersaPro Cream Base for Compounding	marketed

Therapeutic area mix

Addiction Medicine / Pain Management · 1
Pain · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ajou University School of Medicine · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Hospital Universitari de Bellvitge · 1 shared drug class
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · 1 shared drug class
Pfizer Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for CAMC Health System:

Cite this brief

Drug Landscape (2026). CAMC Health System — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/camc-health-system. Accessed 2026-05-16.